Nu Skin Enterprises, Inc. cash flow to debt ratio of 22.04% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Nu Skin Enterprises, Inc.'s free cash flow has decreased 34.42% from $70.16M last year to $46.01M, signaling decreasing performance

Nu Skin Enterprises, Inc.'s debt to equity ratio is 0.49, which means that the company's assets are healthy financed, signaling financial stability.

Nu Skin Enterprises, Inc.'s debt has decreased relative to shareholder equity from 0.73 last year to 0.49 today, signaling strengthened financials

Nu Skin Enterprises, Inc. has a net debt to EBITDA ratio of 0.47x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Nu Skin Enterprises, Inc.'s interest coverage ratio is -0.55, which means that the company struggles to meet interest obligations, signaling financial risk.

Nu Skin Enterprises, Inc.'s profit margin has decreased (85.91%) in the last year from -8.46% to -15.73%, signaling decreasing performance

Nu Skin Enterprises, Inc.'s short-term assets of $547.70M exceed its short-term liabilities of $263.73M

Nu Skin Enterprises, Inc.'s return on assets of -19.29% is lower than the 5.00% threshold, indicating inefficient asset utilization

Nu Skin Enterprises, Inc.'s return on equity of -29.42%, is lower than 15.00%, indicating bad performance

Nu Skin Enterprises, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Nu Skin Enterprises, Inc. had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Nu Skin Enterprises, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Nu Skin Enterprises, Inc. has a free cash flow yield of 18.40%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Nu Skin Enterprises, Inc.'s yearly earnings has increased -209.28% since last year from $-146.59M to $160.20M, signaling increasing performance

Nu Skin Enterprises, Inc.'s yearly revenue has decreased 14.26% since last year from $1.73B to $1.49B, signaling decreasing performance

ROIC -0.97% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Nu Skin Enterprises, Inc.'s 3-year revenue CAGR of -12.61% is negative, indicating declining revenue over the past 3 years

Nu Skin Enterprises, Inc. had revenue growth in only 1 out of 5 years, indicating inconsistent revenue performance

Nu Skin Enterprises, Inc. had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

Nu Skin Enterprises, Inc. has insufficient data to evaluate this check.

Nu Skin Enterprises, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Nu Skin Enterprises, Inc. is undervalued relative to its fair value price of 18.21 based on EBITDA multiple model

Nu Skin Enterprises, Inc. has an EV/EBITDA ratio of 1.43x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Nu Skin Enterprises, Inc. is undervalued relative to its fair value price of 7.90 based on Earnings Fair Value model

Nu Skin Enterprises, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Nu Skin Enterprises, Inc. has a price-to-book ratio of 0.46x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Nu Skin Enterprises, Inc. has a price-to-sales ratio of 0.18x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue